InnovAge Holding Corp. (INNV) stock
INNVNasdaqServices-Health ServicesFiscal year ends June 30
Financials through Q4 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 11/3063% above fair value
$8.91−0.51 (-5.41%)
Close on Nov 18, 2026Market cap $1.22BP/E –Yield –
InnovAge operating income
Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.
InnovAge's operating income for the twelve months ending Jun 30, 2026 was $2.62M. For fiscal 2026 it was $2.62M. The highest annual figure on record is $50.93M in fiscal 2020.
Annual operating income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | Jun 30, 2026 | $2.62M | – |
| FY2025 | Jun 30, 2025 | -$29.76M | – |
| FY2024 | Jun 30, 2024 | -$23.18M | – |
| FY2023 | Jun 30, 2023 | -$49.40M | – |
| FY2022 | Jun 30, 2022 | -$4.41M | – |
| FY2021 | Jun 30, 2021 | -$12.34M | -124.2% |
| FY2020 | Jun 30, 2020 | $50.93M | – |
Quarterly operating income
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2026CQ2 2026 | Jun 30, 2026 | $10.15M | – |
| Q3 FY2026CQ1 2026 | Mar 31, 2026 | -$29.08M | – |
| Q2 FY2026CQ4 2025 | Dec 31, 2025 | $13.26M | – |
| Q1 FY2026CQ3 2025 | Sep 30, 2025 | $8.29M | – |
| Q4 FY2025CQ2 2025 | Jun 30, 2025 | -$2.15M | – |
| Q3 FY2025CQ1 2025 | Mar 31, 2025 | -$10.16M | – |
| Q2 FY2025CQ4 2024 | Dec 31, 2024 | -$12.56M | – |
| Q1 FY2025CQ3 2024 | Sep 30, 2024 | -$4.90M | – |
| Q4 FY2024CQ2 2024 | Jun 30, 2024 | -$4.88M | – |
| Q3 FY2024CQ1 2024 | Mar 31, 2024 | -$5.79M | – |
| Q2 FY2024CQ4 2023 | Dec 31, 2023 | -$1.79M | – |
| Q1 FY2024CQ3 2023 | Sep 30, 2023 | -$10.72M | – |
| Q4 FY2023CQ2 2023 | Jun 30, 2023 | -$10.94M | – |
| Q3 FY2023CQ1 2023 | Mar 31, 2023 | -$8.17M | – |
| Q2 FY2023CQ4 2022 | Dec 31, 2022 | -$13.68M | -563.3% |
| Q1 FY2023CQ3 2022 | Sep 30, 2022 | -$16.60M | -242.4% |
| Q4 FY2022CQ2 2022 | Jun 30, 2022 | -$12.35M | -215.7% |
| Q3 FY2022CQ1 2022 | Mar 31, 2022 | -$6.67M | – |
| Q2 FY2022CQ4 2021 | Dec 31, 2021 | $2.95M | -85.6% |
| Q1 FY2022CQ3 2021 | Sep 30, 2021 | $11.66M | – |
| Q4 FY2021CQ2 2021 | Jun 30, 2021 | $10.67M | -47.1% |
| Q3 FY2021CQ1 2021 | Mar 31, 2021 | -$5.37M | -141.4% |
| Q2 FY2021CQ4 2020 | Dec 31, 2020 | $20.54M | – |
| Q1 FY2021CQ3 2020 | Sep 30, 2020 | -$38.18M | – |
| Q4 FY2020CQ2 2020 | Jun 30, 2020 | $20.17M | – |
| Q3 FY2020CQ1 2020 | Mar 31, 2020 | $12.97M | – |
See a number that looks wrong?